ARID1A and bladder transitional cell carcinoma: Recently, Agaimy and colleagues could not detect loss of ARID1A protein expression in any conventional urothelial bladder cancer case under examination but they observed loss of SWI/SNF components including ARID1A only in rare undifferentiated/dedifferentiated urothelial carcinomas with rhabdoid features [40].